WhiteSwell’s heart failure device promising but patient death rattles results
WhiteSwell has debuted promising early data from a feasibility study on its eLym system in acute decompensated heart failure (ADHF), …
Post
-
-
Latest foreign investment in UK highlights underserved potential of primary care technology
European digital health supplier Doctolib has acquired NHS GP technology supplier Medicus as part of a wider UK expansion strategy …
-
SQ Innovation’s home care oedema treatment shows benefit in new data readout
SQ Innovation’s Lasix Onyu, a drug-device combination therapy for fluid retention (oedema) treatment in chronic heart failure patients, has demonstrated value …
-
DoJ prioritising enterprise-wide fraud in medtech industry
The US Department of Justice (DoJ) is tightening its focus on identifying fraud – with a particular focus on enterprise-wide …
-
Alpha Tau concludes patient enrolment in ReSTART pivotal trial
Alpha Tau Medical has completed patient enrolment in its ReSTART pivotal trial, assessing the efficacy and safety of its Alpha …
-
The road to precision medicine in the cardiovascular field
With the rise of technology in the cardiovascular field, there has been a move towards devices that are smaller and …
-
CoMira concludes lease agreement for plant in Sudair Industrial City, Saudi Arabia
Co-Diagnostics' joint venture (JV) CoMira Diagnostics has completed a lease agreement for its planned manufacturing facility in the Kingdom of Saudi …
-
FDA clears Bright Uro’s abdominal sensor for evaluating bladder dysfunction
Bright Uro’s Glean abdominal sensor has obtained US Food and Drug Administration (FDA) clearance, expanding the company’s broader Glean urodynamics system …
-
FDA greenlights Rivanna’s AI musculoskeletal imaging system
Rivanna’s Accuro XV has secured US Food and Drug Administration (FDA) clearance, setting the stage for the artificial intelligence (AI)-based …
-
Glucotrack seeks FDA approval for clinical study of CBGM technology
Glucotrack has submitted an investigational device exemption (IDE) application to the US Food and Drug Administration (FDA), seeking approval to …
-
Podcast: The implications of NICE’s formal recommendation for cryoablation’s use in treating kidney tumours
In March 2026, the UK's National Institute for Health and Care Excellence (NICE) formally recommend the cryoablation for treating kidney …
-
Microsure receives CE mark for MUSA-3 system and appoints new CEO
Dutch medical technology company Microsure has secured CE mark approval for its MUSA-3 system and appointed Alex Joseph as its …
-
The tech convergence rewriting the story of medical devices
As procedural complexity continues to rise across oncology and women’s health, a range of technologies are rapidly converging. This shift is …
-
BD uplifts FY26 revenue outlook based on steady portfolio performance
In a reversal from its previously reported quarter, Becton Dickinson and Company (BD) has lifted its fiscal year 2026 (FY26) profit …
-
Artera hits US first with pathology-based breast cancer risk tool’s clearance
Artera has obtained US Food and Drug Administration (FDA) clearance for ArteraAI Breast, making it the first digital pathology–based risk …
